Pancreatic Cancer Research

ResearcherHokkaido UniversityNo recent work listed

Yoshitsugu Nakanishi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9300-7751; OpenAlex author ID A5006364648. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 3 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper

Papers 10

  1. Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9. Co-author DOI 10.1245/s10434-022-11630-0↗
  2. A novel laparoscopic near-infrared fluorescence spectrum system for photodynamic diagnosis of peritoneal dissemination in pancreatic cancer. Co-author DOI 10.1016/j.pdpdt.2020.102157↗
  3. Immunological Gene Signature Associated With the Tumor Microenvironment of Pancreatic Cancer After Neoadjuvant Chemotherapy. Co-author DOI 10.1097/mpa.0000000000001665↗
  4. Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target. Co-author DOI 10.1158/1535-7163.mct-19-0491↗
  5. A Preoperative Prognostic Scoring System to Predict Prognosis for Resectable Pancreatic Cancer: Who Will Benefit from Upfront Surgery? Co-author DOI 10.1007/s11605-018-3972-x↗
  6. Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.14023↗
  7. [Ⅲ.Management of Biliary Drainage in Patients Undergoing Neo-Adjuvant Therapy for Biliary or Pancreatic Cancer]. Co-author PMID 31631131↗
  8. Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded favorably to nonsurgical treatment. Co-author DOI 10.1002/jhbp.565↗
  9. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Co-author DOI 10.1186/s40792-018-0506-4↗
  10. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal aden… Co-author DOI 10.1007/s00595-016-1420-7↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takahiro Tsuchikawa · 10 shared papers, 2017–2022 · strength 0.87
  2. Toshimichi Asano · 10 shared papers, 2017–2022 · strength 0.87
  3. Toru Nakamura · 10 shared papers, 2017–2022 · strength 0.87
  4. Satoshi Hirano · 10 shared papers, 2017–2022 · strength 0.87
  5. Toshiaki Shichinohe · 9 shared papers, 2017–2022 · strength 0.77
  6. Shota Kuwabara · 2 shared papers, 2019–2022 · strength 0.19
  7. Masato Ono · 2 shared papers, 2019–2022 · strength 0.19
  8. Yuma Hane · 2 shared papers, 2019–2020 · strength 0.17
  9. Yuko Omori · 1 shared paper, 2022 · strength 0.11
  10. Yusuke Mizukami · 1 shared paper, 2022 · strength 0.11
  11. Toru Furukawa · 1 shared paper, 2022 · strength 0.11
  12. Takahiro Saito · 1 shared paper, 2021 · strength 0.11
  13. Kazuho Inoko · 1 shared paper, 2020 · strength 0.08
  14. Toshihiro Kushibiki · 1 shared paper, 2020 · strength 0.08
  15. Shinya Tanaka · 1 shared paper, 2020 · strength 0.08
  16. Kyoko Hida · 1 shared paper, 2020 · strength 0.08
  17. Osamu Sato · 1 shared paper, 2019 · strength 0.07
  18. M Miyasaka · 1 shared paper, 2018 · strength 0.07
  19. Takeo Nitta · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.